Observational analysis reveals distinct pharmacokinetics of acetone and β-hydroxybutyrate after ketone monoester use, highlighting potential therapeutic strategies.
Motivation: Exogeneous ketone body supplementation may achieve some of the health benefits of ketosis without imposing a restrictive diet and fasting. Goal(s): To investigate the pharmacokinetics of ketone bodies in the brain after ketone monoester (KME) supplementation using high-field 1H-MRS in healthy controls and patients with IDH-mutant glioma. Approach: Participants were measured using 7T 1H-MRS following KME ingestion to non-invasively detect and quantify ketones and cerebral metabolites over time. Results: Ketone signals, i.e., β-hydroxybutyrate and acetone, are clearly resolved in MR spectra. β-hydroxybutyrate level increased immediately after KME-ingestion, peaking around one hour, whereas acetone levels exhibited a more gradual rise. Impact: Ketone monoester supplementation is a complementary therapeutic strategy for many diseases, but data on ketone dynamics in the brain are limited. High-field MRS can be used to investigate pharmacokinetics of ketones in healthy tissue as well as in tumors.
No takes yet. Share an insight, caveat, or question.
Alçiçek et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: